Artivion, Inc. engages in the manufacture, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The company is headquartered in Kennesaw, Georgia and currently employs 1,800 full-time employees. The firm operates through two segments, which include Medical Devices and Preservation Services. The medical devices and preservation services are primarily used by cardiac and vascular surgeons to treat patients with aortic disease, including heart valve disease, aortic aneurysms, and dissections, and, to a lesser extent, other conditions in cardiac and vascular surgery. The company has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products.
Mr. James Mackin 2014 'den beri şirketle birlikte olan Artivion Inc 'in Chairman of the Board 'ıdır.
AORT hissesinin fiyat performansı nasıl?
AORT 'in mevcut fiyatı $0 'dir, son işlem günde 0% azalmış etti.
Artivion Inc için ana iş temaları veya sektörler nelerdir?
Artivion Inc Health Care endüstrisine ait ve sektör Health Care 'dir
Artivion Inc 'in piyasa değerlemesi nedir?
Artivion Inc 'in mevcut piyasa değerlemesi $1.2B 'dir
Artivion Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 9 analist Artivion Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 4 güçlü al, 7 al, 2 tut, 0 sat ve 4 güçlü sat içermektedir